Article

Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text
Advertising


Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates



Journal of the American Academy of Dermatology
Volume 42, n° 3
pages 436-441 (mars 2000)
Doi : 10.1016/S0190-9622(00)90215-9
accepted : 16 August 1999
Rate of body dysmorphic disorder in dermatology patients
 

Katharine A. Phillips, MDa, Raymond G. Dufresne, MDb, Caroline S. Wilkel, MDb, Carmela C. Vittorio, MDb
Providence, Rhode Island 
From Butler Hospital and the Department of Psychiatry and Human Behavior,a and the Department of Dermatology,b Brown University School of Medicine 

Abstract

Background: Dermatologists appear to be the physicians most often seen by patients with the psychiatric condition body dysmorphic disorder (BDD), a distressing or impairing preoccupation with a nonexistent or slight defect in appearance. The frequency of BDD among patients seeking dermatologic treatment is unknown, however. Objective: This study determined the percentage of patients seeking dermatologic treatment who screened positive for BDD. Methods: A validated self-report questionnaire and a reliable defect severity scale were used to determine the rate of BDD in 268 patients seeking dermatologic treatment. Results: A total of 11.9% (95% confidence interval [CI], 8.0%-15.8%) of patients screened positive for BDD. Rates were similar in a community general dermatology setting (14.4% [95% CI, 8.5%-20.3%]) and a university cosmetic surgery setting (10.0% [95% CI, 6.1%-13.9%]). Conclusion: BDD appears relatively common among patients seeking dermatologic treatment. Further research is needed to confirm these findings and to assist dermatologists in identifying these potentially high-risk patients. (J Am Acad Dermatol 2000;42:436-41.)

The full text of this article is available in PDF format.

 Supported by a grant from the National Alliance for Research on Schizophrenia and Depression (NARSAD) to Dr Phillips.
 Reprint requests: Katharine A. Phillips, MD, Butler Hospital, 345 Blackstone Blvd, Providence, RI 02906.



© 2000  American Academy of Dermatology, Inc. Published by Elsevier Masson SAS@@#104157@@
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Close
Article Outline
You can move this window by clicking on the headline